Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Ownership
Insiders
Insiders Menu
Roster
Transactions
Xilio Therapeutics, Inc.
Date
Name
Title
Type
Security
Shares
Price
Value
Ownership
Reported
08/16/2023
Huber Martin H. Jr.
PRESIDENT AND HEAD OF R&D
Grant
Stock Option (right to buy)
136.5k
$2.79
$380.2k
08/16/2023
08/16/2023
Brennan Kevin M.
SVP, FINANCE AND ACCOUNTING
Grant
Stock Option (right to buy)
25k
$2.79
$69.6k
08/16/2023
08/16/2023
Frankenfield Christopher James
COO
Grant
Stock Option (right to buy)
300k
$2.79
$835.5k
08/16/2023
08/16/2023
Russo Rene
CEO
Grant
Stock Option (right to buy)
700k
$2.79
$1.9M
08/16/2023
08/03/2023
Frankenfield Christopher James
COO
Grant
Stock Option (Right to Buy)
150k
$2.75
$412.5k
08/03/2023
04/01/2023
Brennan Kevin M.
SVP, FINANCE AND ACCOUNTING
Grant
Stock Option (right to buy)
55k
$3.17
$174.4k
04/01/2023
01/01/2023
Russo Rene
CEO
Grant
Stock Option (right to buy)
350k
$2.69
$941.5k
01/01/2023
01/01/2023
English Edward C
PRINCIPAL ACCOUNTING OFFICER
Grant
Stock Option (right to buy)
24k
$2.69
$64.6k
01/01/2023
01/01/2023
Huber Martin H. Jr.
PRESIDENT AND HEAD OF R&D
Grant
Stock Option (right to buy)
136.5k
$2.69
$367.2k
01/01/2023
09/15/2022
Heyman Tomas J.
Director
Grant
Stock Option (right to buy)
26.4k
$3.15
$83.2k
09/15/2022
06/15/2022
Bonstein Sara
Director
Grant
Stock Option (right to buy)
13.2k
$2.28
$30.1k
06/15/2022
06/15/2022
Huber Martin H. Jr.
PRESIDENT AND HEAD OF R&D
Grant
Stock Option (right to buy)
20k
$2.28
$45.6k
06/15/2022
06/15/2022
Huber Martin H. Jr.
PRESIDENT AND HEAD OF R&D
Grant
Stock Option (right to buy)
20k
$2.28
$45.6k
06/15/2022
06/15/2022
Rossi Christina
Director
Grant
Stock Option (right to buy)
13.2k
$2.28
$30.1k
06/15/2022
06/15/2022
Ross Michael Jay
Director
Grant
Stock Option (right to buy)
13.2k
$2.28
$30.1k
06/15/2022
06/15/2022
Clancy Paul J
Director
Grant
Stock Option (right to buy)
13.2k
$2.28
$30.1k
06/15/2022
06/15/2022
Xu Yuan
Director
Grant
Stock Option (right to buy)
13.2k
$2.28
$30.1k
06/15/2022
06/15/2022
ROSS ROBERT W.
Director
Grant
Stock Option (right to buy)
26.4k
$2.28
$60.2k
06/15/2022
02/22/2022
Huber Martin H. Jr.
PRESIDENT AND HEAD OF R&D
Grant
Stock Option (right to buy)
65k
$12.66
$822.9k
02/22/2022
02/22/2022
Russo Rene
CEO
Grant
Stock Option (right to buy)
150k
$12.66
$1.9M
02/22/2022
02/22/2022
Giovine Salvatore
CFO
Grant
Stock Option (right to buy)
49.5k
$12.66
$626.7k
02/22/2022
01/04/2022
Xu Yuan
Director
Grant
Stock Option (right to buy)
26.4k
$15.92
$420.3k
01/04/2022
12/22/2021
Russo Rene
CEO
Grant
Stock Option (right to buy)
100k
$13.83
$1.4M
12/22/2021
12/22/2021
Russo Rene
CEO
Grant
Stock Option (right to buy)
100k
$13.83
$1.4M
12/22/2021
12/10/2021
Bain Capital Life Sciences Investors, LLC
10% Owner
Purchase
Common Stock
21.8k
$9.56
$208.6k
See footnotes
12/08/2021
12/10/2021
Bain Capital Life Sciences Investors, LLC
10% Owner
Purchase
Common Stock
3.2k
$10.24
$32.6k
See footnotes
12/08/2021
12/09/2021
Bain Capital Life Sciences Investors, LLC
10% Owner
Purchase
Common Stock
4k
$9.84
$39.5k
See footnotes
12/08/2021
12/08/2021
Bain Capital Life Sciences Investors, LLC
10% Owner
Purchase
Common Stock
13.5k
$9.62
$129.5k
See footnotes
12/08/2021
10/26/2021
Merck KGaA
10% Owner
Conversion
Common Stock
264.8k
$0.00
$0
See Footnote
10/26/2021
10/26/2021
Merck KGaA
10% Owner
Conversion
Series B Preferred Stock
4M
$0.00
$0
See Footnote
10/26/2021
10/26/2021
Merck KGaA
10% Owner
Conversion
Series C Preferred Srock
2.5M
$0.00
$0
See Footnote
10/26/2021
10/26/2021
Merck KGaA
10% Owner
Conversion
Common Stock
416.1k
$0.00
$0
See Footnote
10/26/2021
10/26/2021
SV7 Impact Medicine Fund LP
10% Owner
Conversion
Common Stock
998.5k
$0.00
$0
See footnote
10/26/2021
10/26/2021
SV7 Impact Medicine Fund LP
10% Owner
Conversion
Common Stock
302.6k
$0.00
$0
10/26/2021
10/26/2021
SV7 Impact Medicine Fund LP
10% Owner
Conversion
Common Stock
302.6k
$0.00
$0
See footnote
10/26/2021
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy